Loading clinical trials...
Loading clinical trials...
Phase III Intergroup Trial of Adjuvant Chemoradiation After Resection of Gastric or Gastroesophageal Adenocarcinoma
Conditions
Interventions
cisplatin
epirubicin hydrochloride
+3 more
Locations
535
United States
Regional Medical Center
Anniston, Alabama, United States
Providence Cancer Center at Providence Hospital
Mobile, Alabama, United States
Mayo Clinic Scottsdale
Scottsdale, Arizona, United States
Arizona Cancer Center at University of Arizona Health Sciences Center
Tucson, Arizona, United States
Hembree Mercy Cancer Center at St. Edward Mercy Medical Center
Fort Smith, Arkansas, United States
Ben E. Owens Cancer Treatment Center at St. Bernard's Medical Center
Jonesboro, Arkansas, United States
Start Date
December 1, 2002
Primary Completion Date
June 1, 2012
Completion Date
December 1, 2016
Last Updated
May 7, 2020
NCT04550494
NCT04704661
NCT05489211
NCT05702229
NCT04674267
NCT07217704
Lead Sponsor
Alliance for Clinical Trials in Oncology
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions